Grupo Español de Tumores Huérfanos e Infrecuentes Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2012
NCT01584297
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Grupo Español de Tumores Huérfanos e Infrecuentes